Poverty influences people's behaviour, including preventive behaviour.
In 2025, Nigeria recorded over 102,000 new HIV infections — a figure that speaks not only to a disease, but to the fragility of systems built on borrowed resources and borrowed time. The withdrawal of American funding from PEPFAR, combined with the quiet erosion of poverty and the fading of public awareness, has unraveled decades of careful progress in a country already carrying the world's second-largest HIV burden. What is at stake now is not merely a health statistic, but the question of whether a nation can summon the will and the means to protect its people when the world's attention moves elsewhere.
- With 102,025 new HIV infections recorded in 2025, Nigeria's already strained response infrastructure is buckling under the simultaneous loss of foreign funding, rising poverty, and vanishing public health messaging.
- The US suspension of PEPFAR funding triggered an immediate collapse in testing availability, counseling services, and community outreach — programs Nigeria had come to rely on as the backbone of its HIV response.
- Poverty is driving people away from registered clinics and into unregulated facilities where reused syringes and unsterilized instruments quietly fuel transmission in ways that surveillance systems may never fully capture.
- Medication rationing among the 1.7 million Nigerians on antiretroviral therapy is raising viral loads and increasing the likelihood of onward transmission, turning a supply chain crisis into a public health emergency.
- The government has approved emergency funding — 4.8 billion naira for treatment packs and $200 million in health spending — but doctors warn that without destigmatization and sustained domestic investment, the 2030 control targets will remain out of reach.
Nigeria recorded 102,025 new HIV infections in 2025, a figure that doctors say reflects three converging crises: the collapse of foreign donor support, the deepening grip of poverty, and the near-disappearance of public HIV prevention campaigns. The country is home to roughly two million people living with HIV or AIDS — the world's second-largest burden — and more than 1.7 million of them depend on antiretroviral therapy through a supply chain now visibly strained.
The most immediate trigger was the US decision to halt funding for PEPFAR after Donald Trump took office in January. Nigeria had long relied on that money for testing, counseling, and community education. When it stopped, those services contracted sharply. Hospitals ran short of test kits. Patients reported their medications being rationed. A $160 million humanitarian funding gap was announced by UNICEF in August 2025. The Federal Government responded with emergency allocations, but the damage was already spreading.
Yet physicians point to forces that run deeper than the funding crisis alone. Dr. Dan Onwujekwe, an HIV and tuberculosis specialist, argues that poverty is itself a driver of infection — pushing people toward unregistered clinics where needles are reused and instruments go unsterilized, and shaping behaviors that increase vulnerability. Dr. Sule Abdullahi of Aminu Kano Teaching Hospital adds that HIV has simply faded from public consciousness, crowded out by other health concerns, leaving prevention messaging dangerously quiet.
Both doctors maintain that Nigeria's 2030 targets — ensuring 95 percent of people know their status, receive treatment, and achieve viral suppression — remain achievable, but only through urgent action: domestic funding to replace donor withdrawals, destigmatization to bring more people into care, and a renewal of the public awareness that once made prevention a shared responsibility. The true scale of new infections, Onwujekwe cautions, may be larger still, given the limits of Nigeria's surveillance systems. What comes next depends on whether the government chooses to act before the window closes.
Nigeria recorded 102,025 new HIV infections in 2025, a troubling figure that medical doctors say reflects a convergence of three deepening crises: the withdrawal of foreign donor support, the grinding reality of poverty across the country, and the near-silence of public health campaigns that once kept HIV prevention visible in people's minds.
The numbers carry weight. Roughly two million Nigerians are living with HIV or AIDS, making the country home to the world's second-largest burden of the disease. More than 1.7 million of those are on antiretroviral therapy—a lifeline that depends on a fragile supply chain now under strain. In August 2025, the United Nations Children's Fund announced a $160 million funding gap for humanitarian aid in Nigeria alone. Hospitals across the country have run short of test kits. People already infected report that their medications are being rationed. The Federal Government approved 4.8 billion naira for 150,000 treatment packs and allocated an additional $200 million to health spending to absorb some of the shock, but the damage is visible on the ground.
The immediate cause is clear: the United States halted funding for PEPFAR—the President's Emergency Plan for AIDS Relief, a two-decade-old global health initiative—after Donald Trump took office in January as the 47th president. Nigeria, like many countries with limited domestic resources, had come to depend on this money for testing services, counseling, education, and community support. When the funding stopped, those programs contracted or closed. Testing became less available. Treatment access narrowed. Awareness campaigns that had helped shape public behavior simply ended.
But doctors interviewed by this publication point to something deeper than the funding crisis alone. Dr. Dan Onwujekwe, a tuberculosis and HIV specialist and former senior researcher at the Nigerian Institute of Medical Research, traces much of the rise in infections to poverty itself. When people lack money, he explains, they avoid registered health facilities and seek care in unregistered clinics run by people with no medical training, often in rural areas. In those settings, medical equipment may not be properly sterilized. Syringes and needles are washed and reused. Sharp instruments in barber shops, hair salons, and beauty parlors pose an unquantified but real risk of transmission. Poverty also shapes behavior in ways that increase vulnerability to infection—people take risks they might otherwise avoid. "Poverty influences people's behaviour, including preventive behaviour," Onwujekwe said. "The spread of infection can occur when appropriate preventive measures are not taken."
Dr. Sule Abdullahi, an associate professor of obstetrics and gynecology at Aminu Kano Teaching Hospital in Kano, emphasizes the visibility problem. "You hardly hear as much about HIV prevention today because attention has shifted to other diseases," he said. When people stop taking antiretroviral drugs—because supplies are interrupted or inconsistent—their viral load rises, making transmission more likely. The cascade of consequences is straightforward: less funding means less testing, which means fewer people know their status. Fewer people on treatment means more transmission. Less public messaging means less prevention.
Both doctors stress that the 95-95-95 targets—the global goal to ensure 95 percent of people know their HIV status, 95 percent of those diagnosed receive sustained treatment, and 95 percent of those on treatment achieve viral suppression by 2030—remain theoretically achievable, but only if Nigeria acts decisively. Onwujekwe calls for destigmatization efforts that would encourage more people to come forward for testing and treatment. Abdullahi emphasizes that domestic funding must fill the gap left by donor withdrawal, and that Nigerians must continue to protect themselves through safer sex practices. The 102,025 infections recorded in 2025 may represent only a fraction of the true burden, Onwujekwe notes, given Nigeria's size and the limits of surveillance systems. What happens next depends on whether the government commits the resources to reverse course.
Notable Quotes
Poverty influences people's behaviour, including preventive behaviour. The spread of infection can occur when appropriate preventive measures are not taken.— Dr. Dan Onwujekwe, TB/HIV specialist and former senior researcher at Nigerian Institute of Medical Research
You hardly hear as much about HIV prevention today because attention has shifted to other diseases. These are some of the factors contributing to the increase in new infections.— Dr. Sule Abdullahi, associate professor of obstetrics and gynecology at Aminu Kano Teaching Hospital
The Hearth Conversation Another angle on the story
Why did the funding cuts hit so hard? Couldn't Nigeria have absorbed the loss?
The system was built on donor money. Testing, counseling, treatment supplies—all of it flowed through programs funded by PEPFAR and other foreign sources. Nigeria didn't have the domestic infrastructure to replace that overnight. When it stopped, the whole apparatus contracted.
But the government approved new spending. Didn't that help?
It helped, but it wasn't enough and it came late. Four point eight billion naira for 150,000 treatment packs sounds substantial until you realize two million people are living with HIV. The money is real, but the gap is still enormous.
The poverty angle seems almost separate from the funding crisis. Are they connected?
They're intertwined. Poverty existed before the funding cuts, but it becomes more dangerous when public health infrastructure weakens. Poor people already use unregistered clinics where needles are reused. When awareness campaigns disappear, they have even less information about risk. When testing becomes scarce, they're less likely to know their status.
So the 102,025 new infections—is that the real number?
It's the official number. But one of the doctors said it's probably just the tip of the iceberg. Nigeria is vast. Many infections go undetected, unreported. The true burden is likely much higher.
Can they still hit the 95-95-95 targets by 2030?
Both doctors said it's possible but difficult. It requires the government to actually release the domestic funding it promised, to destigmatize HIV so people come forward for testing, and to rebuild the awareness campaigns that have gone quiet. Without those things, the targets slip further away.
What would actually turn this around?
Sustained domestic funding, first. Then destigmatization—making sure HIV status doesn't cost someone their job or their place in society. And visibility. People need to hear about prevention again. Right now, the conversation has moved on to other diseases.